Apogee Therapeutics, Inc.7月10日成交额为4947.18万美元

市场透视07-11

美东时间2025年7月10日，Apogee Therapeutics, Inc.（APGE.US）成交额为4947.18万美元，成交额较昨日减少51.17%，当日成交量为130.10万股。Apogee Therapeutics, Inc.（APGE.US）于2025年7月10日涨4.19%，报38.57美元，该股过去5个交易日跌12.97%，年初至今跌14.86%，过去60日涨21.29%。|近5...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2550608426?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-11 09:17","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2550608426","market":"us","top_or_hot":-1,"title":"Apogee Therapeutics, Inc.7月10日成交额为4947.18万美元","media":"市场透视","content":"<div>\n<p>美东时间2025年7月10日，Apogee Therapeutics, Inc.（APGE.US）成交额为4947.18万美元，成交额较昨日减少51.17%，当日成交量为130.10万股。Apogee Therapeutics, Inc.（APGE.US）于2025年7月10日涨4.19%，报38.57美元，该股过去5个交易日跌12.97%，年初至今跌14.86%，过去60日涨21.29%。|近5...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711091737a4438a40&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apogee Therapeutics, Inc.7月10日成交额为4947.18万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApogee Therapeutics, Inc.7月10日成交额为4947.18万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-11 09:17 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711091737a4438a40&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>美东时间2025年7月10日，Apogee Therapeutics, Inc.（APGE.US）成交额为4947.18万美元，成交额较昨日减少51.17%，当日成交量为130.10万股。Apogee Therapeutics, Inc.（APGE.US）于2025年7月10日涨4.19%，报38.57美元，该股过去5个交易日跌12.97%，年初至今跌14.86%，过去60日涨21.29%。|近5...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711091737a4438a40&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711091737a4438a40&s=b","article_id":"2550608426","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711091737a4438a40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2550608426","pubTimestamp":1752196650,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"美东时间2025年7月10日，Apogee Therapeutics, Inc.成交额为4947.18万美元，成交额较昨日减少51.17%，当日成交量为130.10万股。Apogee Therapeutics, Inc.于2025年7月10日涨4.19%，报38.57美元，该股过去5个交易日跌12.97%，年初至今跌14.86%，过去60日涨21.29%。其抗体项目旨在通过靶向成熟的作用机制并结合抗体工程来优化半衰期和其他特性，从而克服现有疗法的局限性。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","APGE":"Apogee Therapeutics","BK4539":"次新股","BK4139":"生物科技","LENZ":"Therapeutics"},"translate_title":"Apogee Therapeutics, Inc. turnover of $49.4718 million on July 10","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"APGE":1},"content_text":"美东时间2025年7月10日，Apogee Therapeutics, Inc.（APGE.US）成交额为4947.18万美元，成交额较昨日减少51.17%，当日成交量为130.10万股。Apogee Therapeutics, Inc.（APGE.US）于2025年7月10日涨4.19%，报38.57美元，该股过去5个交易日跌12.97%，年初至今跌14.86%，过去60日涨21.29%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-10|4947.18万|-51.17%|130.10万|#|2025-07-09|1.01亿|-7.88%|270.54万|#|2025-07-08|1.10亿|-54.39%|298.56万|#|2025-07-07|2.41亿|923.96%|601.16万|#|2025-07-03|2354.88万|-64.12%|50.80万|Apogee Therapeutics Inc 是一家生物技术公司，致力于开发差异化的生物制剂，用于治疗特应性皮炎 （AD）、慢性阻塞性肺病 （COPD） 以及具有高度未满足需求的相关炎症和免疫学 （I&I） 适应症。其抗体项目旨在通过靶向成熟的作用机制并结合抗体工程来优化半衰期和其他特性，从而克服现有疗法的局限性。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2550608426","isCrawlerRequest":true}